LACK WALTER J 4
4 · Astex Pharmaceuticals, Inc · Filed Jul 3, 2012
Insider Transaction Report
Form 4
LACK WALTER J
Director
Transactions
- Exercise/Conversion
Common Stock
2012-06-29$2.14/sh+15,000$32,100→ 395,000 total - Exercise/Conversion
Director Stock Option (Right to buy)
2012-06-29−10,000→ 0 totalExercise: $2.14Exp: 2020-06-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2012-06-29$2.14/sh+10,000$21,400→ 415,000 total - Exercise/Conversion
Common Stock
2012-06-29$2.14/sh+10,000$21,400→ 405,000 total - Exercise/Conversion
Director Stock Option (Right to buy)
2012-06-29−15,000→ 0 totalExercise: $2.14Exp: 2020-06-10→ Common Stock (15,000 underlying) - Exercise/Conversion
Director Stock Option (Right to buy)
2012-06-29−10,000→ 0 totalExercise: $2.14Exp: 2020-06-10→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]3,750 shares of the 15,000 share option grant became exercisable on the June 10, 2010 grant date and on each three month anniversary thereafter.
- [F2]2,500 shares of the 10,000 share option grant became exercisable on the June 10, 2010 grant date and on each three month anniversary therafter.